Phase 2 Vitiligo Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a specific type of vitiligo called "non-segmental vitiligo" for at least 3 months
- The vitiligo affects between 4% and 60% of your body's skin surface (not counting the palms of your hands, soles of your feet, or the tops of your feet)
- At least a small amount of vitiligo (0.5% or more) is visible on your face
- Your vitiligo scores meet specific measurements for both face and body that the trial team will check (confirm with trial site)
- Your vitiligo is either currently spreading or has been stable — both are acceptable
Who may not be able to join:
- You have a different type of vitiligo other than the kind described above
- You currently have another active condition affecting your skin's pigmentation (colouring)
- You currently have an active inflammatory skin condition or other skin problem that could make it hard to assess the vitiligo
- You have had a skin infection in the 2 weeks before starting the trial (you may be able to try again after the infection clears up)
- You have had a history of serious alcohol misuse, intravenous drug use, or other illegal drug use in the past year
- You have a history of serious or unstable heart, lung, liver, digestive, hormonal, blood, nerve, or mental health conditions that the trial doctor believes could put you at risk or affect the results
- You have ever used any medication from a group called "JAK inhibitors" — either as a cream/ointment or as a pill/injection — at any point in the past (examples include ruxolitinib, tofacitinib, and baricitinib)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 1-317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants Achieving Facial Vitiligo Area Scoring Index (F-VASI) 75
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.